131 related articles for article (PubMed ID: 6271161)
1. Enhanced monocyte and neutrophil cytotoxicity and normal cyclic nucleotide levels in severe psoriasis.
Herlin T; Kragballe K
Br J Dermatol; 1981 Oct; 105(4):405-13. PubMed ID: 6271161
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of enhanced monocyte and neutrophil cytotoxicity in severe psoriasis.
Herlin T; Borregaard N; Kragballe K
J Invest Dermatol; 1982 Aug; 79(2):104-8. PubMed ID: 6284840
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil chemotaxis in psoriasis.
Wahba A; Cohen H; Bar-Eli M; Callily R
Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368
[TBL] [Abstract][Full Text] [Related]
4. Colchicine in generalized pustular psoriasis: clinical response and antibody-dependent cytotoxicity by monocytes and neutrophils.
Zachariae H; Kragballe K; Herlin T
Arch Dermatol Res; 1982; 274(3-4):327-33. PubMed ID: 6762163
[TBL] [Abstract][Full Text] [Related]
5. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
Ternowitz T
J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
[TBL] [Abstract][Full Text] [Related]
6. Transient cyclic AMP accumulation during antibody-dependent cytotoxicity mediated by monocytes and neutrophils.
Herlin T; Kragballe K
Immunology; 1981 Aug; 43(4):771-8. PubMed ID: 6268530
[TBL] [Abstract][Full Text] [Related]
7. Normalization of monocyte chemotaxis precedes clinical resolution of psoriasis treated with benoxaprofen.
Kragballe K; Ternowitz S; Herlin T
Acta Derm Venereol; 1985; 65(4):319-23. PubMed ID: 2413686
[TBL] [Abstract][Full Text] [Related]
8. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
[TBL] [Abstract][Full Text] [Related]
9. The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.
Ternowitz T
J Am Acad Dermatol; 1987 Jun; 16(6):1169-75. PubMed ID: 3597858
[TBL] [Abstract][Full Text] [Related]
10. Monocyte function in psoriasis.
Bar-Eli M; Gallily R; Cohen HA; Wahba A
J Invest Dermatol; 1979 Aug; 73(2):147-9. PubMed ID: 379240
[TBL] [Abstract][Full Text] [Related]
11. The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis.
Saihan EM; Albano J; Burton JL
Br J Dermatol; 1980 May; 102(5):565-9. PubMed ID: 6248098
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte cyclic nucleotide and prostaglandin content in psoriasis: a preliminary report.
Harpaz S; Fink A; Zuckerman F; Muhammad E
Arch Dermatol; 1980 Apr; 116(4):427-8. PubMed ID: 6245622
[TBL] [Abstract][Full Text] [Related]
13. Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.
Herlin T; Eggert J; Kragballe K; Zachariae H
Arch Dermatol Res; 1984; 276(5):279-82. PubMed ID: 6091571
[TBL] [Abstract][Full Text] [Related]
14. The localization of cyclic nucleotides in the human epidermis: an immunohistochemical study.
Mizumoto T; Ohkawara A
Curr Probl Dermatol; 1980; 10():67-81. PubMed ID: 6263551
[TBL] [Abstract][Full Text] [Related]
15. Impaired monocyte cyclic AMP responses and monocyte cytotoxicity in atopic dermatitis.
Herlin T; Kragballe K
Allergy; 1980 Dec; 35(8):647-55. PubMed ID: 6261605
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil leukocyte migration in psoriasis vulgaris.
Breathnach SM; Carrington P; Black MM
J Invest Dermatol; 1981 Apr; 76(4):271-4. PubMed ID: 7205028
[TBL] [Abstract][Full Text] [Related]
17. Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis.
Majewski S; Wasik M; Jabłońska S; Kamiński M; Fraczykowska M
Arch Dermatol Res; 1986; 278(4):264-9. PubMed ID: 3740937
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-mediated-antibody-dependent cellular cytotoxicity in malignant lymphoma and solid tumors.
de Mulder PH; de Pauw BE; van de Ven EC; Wagener TD; Haanen C
Cancer; 1984 Jun; 53(11):2444-9. PubMed ID: 6713346
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotides and prostaglandins in psoriasis.
Raab WP
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):212-24. PubMed ID: 6248471
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP and cyclic GMP production in normal and psoriatic epidermis.
Royer E; Chaintreul J; Meynadier J; Michel B; Guilhou JJ; Crastes de Paulet A
Dermatologica; 1982; 165(6):533-43. PubMed ID: 6301901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
